My Quote Request
No products added yet
6505-01-166-3799
20 Products
SULF-10
SULFACETAMIDE SODIUM OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011663799
NSN
6505-01-166-3799
SULF-10
SULFACETAMIDE SODIUM OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011663799
NSN
6505-01-166-3799
MFG
COOPER LABORATORIES INC COOPER VISION PHARMACEUTICALS INC DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V SULFACETAMIDE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: TUBE WITH OPHTHALMIC TIP, COLLAPSIBLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
C-1/2
CALCIUM ACETATE FOR INJECTION
NSN, MFG P/N
6505011664385
NSN
6505-01-166-4385
MFG
ORGANON INC ORGANON TEKNIKA CORP SUB OF AKZONE INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.300 GRAMS CALCIUM ACETATE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.300 GRAMS
PRIMARY CONTAINER TYPE: PACKET
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
0069682
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
0069682
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
MFG
ASSOCIATION PHARMACEUTIQUE BELGE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 PERCENTAGE, W/V DIPIVEFRIN HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP 5ML BT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
NDC00364-3040-53
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
NDC00364-3040-53
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
MFG
SCHEIN PHARMACEUTICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 PERCENTAGE, W/V DIPIVEFRIN HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP 5ML BT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
NDC11980-0260-25
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
NDC11980-0260-25
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 PERCENTAGE, W/V DIPIVEFRIN HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP 5ML BT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
NDC24208-0540-05
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
NDC24208-0540-05
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
MFG
BAUSCH & LOMB PHARMACEUTICALS DIV BAUSCH & LOMB PHAMACEUTICAL
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 PERCENTAGE, W/V DIPIVEFRIN HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP 5ML BT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
NDC61314-0235-05
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
NDC61314-0235-05
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
MFG
FALCON PHARMACEUTICALS LTD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 PERCENTAGE, W/V DIPIVEFRIN HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP 5ML BT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
PROPINE
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
PROPINE
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 PERCENTAGE, W/V DIPIVEFRIN HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP 5ML BT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
PROPINE COLLYRE 0.1/5ML
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
PROPINE COLLYRE 0.1/5ML
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 PERCENTAGE, W/V DIPIVEFRIN HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP 5ML BT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
S01EA02
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
S01EA02
DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011664386
NSN
6505-01-166-4386
MFG
WHO COLLABORATING CENTRE FOR DRUG STATISTICS METHODOLOGY NORWEGIAN INSTITUTE OF PIBLIC HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 PERCENTAGE, W/V DIPIVEFRIN HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP 5ML BT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
12-815
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011664390
NSN
6505-01-166-4390
12-815
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011664390
NSN
6505-01-166-4390
MFG
COBE LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.250 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 103.250 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 137.500 MILLIEQUIVALENTS SODIUM ION PER LITER AND 39.250 MILLIEQUIVALENTS ACETATE ION PER LITER AND 0.750 MILLIEQUIVALENTS MAGNESIUM ION PER LITER AND
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION WITH 34 PARTS WATER
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: 1.000 MILLIEQUIVALENTS POTASSIUM ION PER LITER
Related Searches:
ACETATE RENALYTE
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011664390
NSN
6505-01-166-4390
ACETATE RENALYTE
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011664390
NSN
6505-01-166-4390
MFG
COBE LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.250 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 103.250 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 137.500 MILLIEQUIVALENTS SODIUM ION PER LITER AND 39.250 MILLIEQUIVALENTS ACETATE ION PER LITER AND 0.750 MILLIEQUIVALENTS MAGNESIUM ION PER LITER AND
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION WITH 34 PARTS WATER
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: 1.000 MILLIEQUIVALENTS POTASSIUM ION PER LITER
Related Searches:
NDC00054-8529-04
LITHIUM CITRATE SYRUP,USP
NSN, MFG P/N
6505011666610
NSN
6505-01-166-6610
NDC00054-8529-04
LITHIUM CITRATE SYRUP,USP
NSN, MFG P/N
6505011666610
NSN
6505-01-166-6610
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.600 MILLIEQUIVALENTS LITHIUM ION PER 5 MILLILITERS
ADMINISTRATION: ORAL
FLAVOR: RASPBERRY
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: CUP, UNIT DOSE
SPECIAL FEATURES: SUGAR FREE
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
4084
ANTIVENIN,LATRODECTUS MACTANS,USP
NSN, MFG P/N
6505011667821
NSN
6505-01-166-7821
4084
ANTIVENIN,LATRODECTUS MACTANS,USP
NSN, MFG P/N
6505011667821
NSN
6505-01-166-7821
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIVENIN LATRADECTUS MACTANS USP CRYSTALLINE POWDER SINGLE DOSE VIAL
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
IMMEDIATE CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: NON-PYROGENIC,CRYSTALLINE POWDER,SINGLE DOSE VIAL CONTAINING NOT LESS THAN 6000 ANTIVENIN UNITS,1 SUCH VIAL SHALL BE PACKAGED TOGETHER WITH A 1 ML VIAL OF NORMAL HORSE SERUM AND A 2.5 ML VIAL OF STERILE DILUENT FOR INJECTION
UNIT PACKAGE QUANTITY: 2
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
ANTIVENIN-SPIDER
ANTIVENIN,LATRODECTUS MACTANS,USP
NSN, MFG P/N
6505011667821
NSN
6505-01-166-7821
ANTIVENIN-SPIDER
ANTIVENIN,LATRODECTUS MACTANS,USP
NSN, MFG P/N
6505011667821
NSN
6505-01-166-7821
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIVENIN LATRADECTUS MACTANS USP CRYSTALLINE POWDER SINGLE DOSE VIAL
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
IMMEDIATE CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: NON-PYROGENIC,CRYSTALLINE POWDER,SINGLE DOSE VIAL CONTAINING NOT LESS THAN 6000 ANTIVENIN UNITS,1 SUCH VIAL SHALL BE PACKAGED TOGETHER WITH A 1 ML VIAL OF NORMAL HORSE SERUM AND A 2.5 ML VIAL OF STERILE DILUENT FOR INJECTION
UNIT PACKAGE QUANTITY: 2
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
NDC00006-4084-00
ANTIVENIN,LATRODECTUS MACTANS,USP
NSN, MFG P/N
6505011667821
NSN
6505-01-166-7821
NDC00006-4084-00
ANTIVENIN,LATRODECTUS MACTANS,USP
NSN, MFG P/N
6505011667821
NSN
6505-01-166-7821
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIVENIN LATRADECTUS MACTANS USP CRYSTALLINE POWDER SINGLE DOSE VIAL
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
IMMEDIATE CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: NON-PYROGENIC,CRYSTALLINE POWDER,SINGLE DOSE VIAL CONTAINING NOT LESS THAN 6000 ANTIVENIN UNITS,1 SUCH VIAL SHALL BE PACKAGED TOGETHER WITH A 1 ML VIAL OF NORMAL HORSE SERUM AND A 2.5 ML VIAL OF STERILE DILUENT FOR INJECTION
UNIT PACKAGE QUANTITY: 2
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
NDC00067-0200-68
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011668989
NSN
6505-01-166-8989
NDC00067-0200-68
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011668989
NSN
6505-01-166-8989
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
Related Searches:
NDC00075-0200-00
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011668989
NSN
6505-01-166-8989
NDC00075-0200-00
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011668989
NSN
6505-01-166-8989
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
Related Searches:
NDC00258-3634-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011668989
NSN
6505-01-166-8989
NDC00258-3634-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011668989
NSN
6505-01-166-8989
MFG
INWOOD LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
Related Searches:
NDC00603-5951-21
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011668989
NSN
6505-01-166-8989
NDC00603-5951-21
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011668989
NSN
6505-01-166-8989
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
